Shah Metacorp Limited
SHAH METACORP LIMITED has informed the Exchange regarding Allotment of Securities |SUBJECT: Alteration Of Capital and Fund Raising-XBRL
SHAH METACORP LIMITED has informed the Exchange regarding Allotment of Securities |SUBJECT: Alteration Of Capital and Fund Raising-XBRL
TATA TECHNOLOGIES LIMITED has informed the Exchange about Board Meeting to be held on 14-Jul-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2025 . |SUBJECT:…
PAVNA INDUSTRIES LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent |SUBJECT: Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
MRF Limited has informed the Exchange that Record date for the purpose of payment of Final Dividend is 18-Jul-2025. |SUBJECT: Record Date
Bengaluru (Karnataka) [India], July 3: Over three transformative days, art and advocacy came together in the heart of Bengaluru for the first-ever SDGs Through Arts – India Edition. Hosted at the prestigious Conrad Bengaluru, the…
New Delhi [India], July 3: The life of a modern doctor is a balancing act. Between managing patient care, keeping up with new medical developments, handling compliance, and coordinating with pharmaceutical representatives, a physician’s day…
New Delhi [India], July 3: The grand finale of Mrs INDIA Empress of The Nation 2025 Season 6 – the brainchild of its Owners: Karl & Anjana Mascarenhas unfolded in style on 29th June 2025,…
Alembic Pharmaceuticals Limited has informed the Exchange regarding ‘Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015’ that Alembic Pharmaceuticals Inc., wholly owned subsidiary of Alembic Pharmaceuticals Limited has acquired Utility…
Significant increase in volume has been observed in Latent View Analytics Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that…
Biocon Limited has informed the Exchange regarding a press release dated July 03, 2025, titled “Advancing Bone Health: European Commission ApprovesBiocon Biologics Denosumab Biosimilars”. |SUBJECT: Press Release